Clinical Trial Update: Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss [Phase 3]

View source ↗

Summary

Phase 3 trial update for the Librata endometrial ablation device evaluating reduction in menstrual blood loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Menorrhagia

Drugs mentioned

• Librata

Snippet

Sponsor: LiNA Medical | Conditions: Menorrhagia, Heavy Menstrual Bleeding | Phase 3 | Status: UNKNOWN